Dipalmitoylphosphatidylcholine modulates inflammatory functions of monocytic cells independently of mitogen activated

A Tonks1, R H Morris, A J Price

  • 1School of Applied Sciences, University of Wales Institute, Cardiff, UK.

Insights

Dipalmitoylphosphatidylcholine (DPPC), a key pulmonary surfactant component, inhibits inflammatory responses in human monocytes. This effect is linked to altered cell membrane fluidity, not MAPK signaling pathways.

Area of Science:

  • Pulmonary immunology
  • Cellular biology
  • Lipid biochemistry

Background:

  • Phosphatidylcholine (PC) is a major phospholipid in pulmonary surfactant.
  • PC subspecies are hypothesized to modulate alveolar macrophage functions.
  • Dipalmitoylphosphatidylcholine (DPPC) is the most abundant PC subspecies.

Purpose of the Study:

  • To investigate the effect of PC on monocyte function.
  • To determine if DPPC modulates oxidative and inflammatory responses in human monocytes.
  • To explore the underlying mechanisms, including membrane fluidity and MAPK signaling.

Main Methods:

  • Utilized the human monocytic cell line MonoMac-6 (MM6).
  • Assessed oxidative response to zymosan and phorbol-12-myristate-13-acetate (PMA) after DPPC preincubation.
  • Measured TNF-alpha release and MAPK phosphorylation (p44/p42, p38).
  • Analyzed changes in MM6 cell membrane fluidity using spin label EPR spectroscopy.

Main Results:

  • DPPC preincubation significantly inhibited MM6 cell oxidative response to zymosan and PMA by 30%.
  • DPPC, along with total PC (tPC), significantly inhibited TNF-alpha release, while 1-palmitoyl-2-arachidonoyl phosphatidylcholine (PAPC) did not.
  • DPPC incorporation significantly altered MM6 cell membrane fluidity.
  • DPPC did not inhibit p44/p42 or p38 MAPK phosphorylation in stimulated cells.

Conclusions:

  • DPPC, a major pulmonary surfactant component, modulates human monocyte inflammatory responses.
  • The observed modulation is potentially linked to alterations in cell membrane fluidity.
  • DPPC's anti-inflammatory effects do not appear to involve the p44/p42 or p38 MAPK signaling pathways.

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...